Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Travers JB et al. | Identification of sn-2 acetyl glycerophosphocholines in human keratinocytes. | 1997 | J Lipid Mediat Cell Signal | pmid:9246603 |
Dupuis F et al. | Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. | 1997 | J Lipid Mediat Cell Signal | pmid:9246601 |
Barnett CC et al. | Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release. | 1997 | J. Surg. Res. | pmid:9245567 |
Nakajima K et al. | Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor. | 1997 | J. Biol. Chem. | pmid:9242626 |
Henninger DD et al. | Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. | 1997 | Circ. Res. | pmid:9242189 |
Davies MG and Hagen PO | Systemic inflammatory response syndrome. | 1997 | Br J Surg | pmid:9240130 |
Bunting M et al. | Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. | 1997 | J. Clin. Invest. | pmid:9239403 |
Sengoku K et al. | Involvement of protein kinases in platelet activating factor-induced acrosome reaction of human spermatozoa. | 1996 | Mol. Hum. Reprod. | pmid:9238710 |
Roussev RG et al. | Embryonic origin of preimplantation factor (PIF): biological activity and partial characterization. | 1996 | Mol. Hum. Reprod. | pmid:9237230 |
Filep JG et al. | Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. | 1997 | Circulation | pmid:9236448 |
Wang X and Evans RD | Effect of endotoxin and platelet-activating factor on lipid oxidation in the rat heart. | 1997 | J. Mol. Cell. Cardiol. | pmid:9236145 |
Pearson JM et al. | Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. | 1997 | Toxicology | pmid:9231696 |
Triggiani M et al. | Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. | 1997 | Am. J. Respir. Crit. Care Med. | pmid:9230731 |
DÃaz O et al. | Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. | 1997 | Am. J. Respir. Crit. Care Med. | pmid:9230720 |
Evans DJ et al. | Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. | 1997 | Am. J. Respir. Crit. Care Med. | pmid:9230719 |
Rhee CK et al. | Effects of platelet activating factor on vascular permeability of the middle ear mucosa. | 1997 | Ann. Otol. Rhinol. Laryngol. | pmid:9228864 |
Ammit AJ and O'Neill C | Studies of the nature of the binding by albumin of platelet-activating factor released from cells. | 1997 | J. Biol. Chem. | pmid:9228051 |
Sirois MG and Edelman ER | VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. | 1997 | Am. J. Physiol. | pmid:9227554 |
Stahl GL et al. | Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. | 1997 | Am. J. Physiol. | pmid:9227410 |
Denault S et al. | Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes. | 1997 | Immunology | pmid:9227331 |
Dupuis F et al. | Production and metabolism of platelet-activating factor by human bone marrow cells. | 1997 | Res. Immunol. | pmid:9226766 |
Serra MF et al. | Anti-allergic properties of the natural PAF antagonist yangambin. | 1997 | Planta Med. | pmid:9225600 |
Lopes AH et al. | Effect of platelet-activating factor on the process of cellular differentiation of Herpetomonas muscarum muscarum. | 1997 Jul-Aug | J. Eukaryot. Microbiol. | pmid:9225446 |
Korotaeva AA et al. | Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins. | 1997 | Membr Cell Biol | pmid:9225256 |
Schwartz JD et al. | Lexipafant inhibits platelet activating factor enhanced neutrophil functions. | 1997 | J. Surg. Res. | pmid:9224389 |
Winkler JD et al. | Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. | 1997 | Biochim. Biophys. Acta | pmid:9219900 |
Svetlov SI et al. | Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. | 1997 | Biochim. Biophys. Acta | pmid:9219895 |
Balestrieri ML et al. | The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells. | 1997 | J. Biol. Chem. | pmid:9211886 |
Hoffman BF et al. | Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. | 1997 | J. Cardiovasc. Electrophysiol. | pmid:9209969 |
Bellone G et al. | Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. | 1997 | Blood | pmid:9207433 |
Zhang S et al. | [Determination of platelet activating factor and platelet associated IgG in pregnancy-induced hypertension]. | 1996 | Zhonghua Fu Chan Ke Za Zhi | pmid:9206185 |
Liu B et al. | Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs. | 1996 | Chin. Med. J. | pmid:9206081 |
Lin J et al. | Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. | 1997 | Acta Otolaryngol. | pmid:9199527 |
Rocha MF et al. | Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. | 1997 | Infect. Immun. | pmid:9199444 |
Rodriguez-Roisin R | Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. | 1997 | Eur. Respir. J. | pmid:9192945 |
Sharma R et al. | Direct effects of platelet-activating factor on glomerular capillary permeability. | 1997 | Kidney Blood Press. Res. | pmid:9192907 |
Teixeira MM et al. | Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. | 1997 | Blood | pmid:9192781 |
Hinterleitner TA et al. | Platelet-activating factor contributes to immune cell and oxidant-mediated intestinal secretion. | 1997 | J. Pharmacol. Exp. Ther. | pmid:9190862 |
Chen J and Giri SN | Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. | 1997 | J. Pharmacol. Exp. Ther. | pmid:9190835 |
van der Weiden RM and Wouters JM | Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption. | 1997 | Br. J. Rheumatol. | pmid:9189067 |
Lacasse C et al. | Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. | 1997 | Inflammation | pmid:9187959 |
Okubo Y et al. | Inhibitory effects of theophylline and procaterol on eosinophil function. | 1997 | Intern. Med. | pmid:9187566 |
Mathiak G et al. | Platelet-activating factor (PAF) in experimental and clinical sepsis. | 1997 | Shock | pmid:9185238 |
Bazan HE and Tao Y | PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration. | 1997 | J Ocul Pharmacol Ther | pmid:9185044 |
Ephgrave K et al. | The role of platelet-activating factor in conscious, normotensive endotoxemia. | 1997 | J. Surg. Res. | pmid:9184676 |
Salcedo R et al. | Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase. | 1997 | Exp. Cell Res. | pmid:9184073 |
Stotland MA and Kerrigan CL | The role of platelet-activating factor in musculocutaneous flap reperfusion injury. | 1997 | Plast. Reconstr. Surg. | pmid:9180723 |
Kelefiotis D and Vakirtzi-Lemonias C | Kinetics of PAF transfer, distribution and metabolism in human blood in vitro. | 1997 | Life Sci. | pmid:9180364 |
Vasänge M et al. | A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. | 1997 | J. Pharm. Pharmacol. | pmid:9178195 |
Lin CN et al. | 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. | 1997 | J. Pharm. Pharmacol. | pmid:9178190 |